Featuring identity verification using artificial intelligence (AI), LabPort was designed to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments
Obseva announced previously that the company has entered into a partnership with Syneos Health to support commercialization of linzagolix in the US and EU
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
The initiative will engage adolescents and youth of India in decisions about their reproductive health
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
The consideration for the acquisition is US $ 2.25 million
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
ANG Lifesciences India Limited has reported financial results for the period ended September 30, 2021
The list of kids with co-morbidities eligible for vaccination would be announced by the government
Subscribe To Our Newsletter & Stay Updated
